{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-301997","form_type":"8-K","ticker":"GRTX","cik":"0001563577","company_name":"Galera Therapeutics, Inc.","filed_at":"2026-07-13T20:01:13+00:00","discovered_at":"2026-07-13T20:02:08.776424+00:00","generated_at":"2026-07-13T20:02:20.388056+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Galera Therapeutics effects 1-for-200 reverse stock split; shares to trade under GRTXD on OTCQB","bullets":["Reverse stock split of common stock at 1:200 ratio effective July 12, 2026.","No fractional shares; stockholders receive cash value based on closing price prior to split.","Outstanding options and warrants adjusted proportionally with exercise price increases.","Common stock begins trading on OTCQB under ticker GRTXD on July 13, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-301997","json":"https://secwatch.observer/filing/0001193125-26-301997.json","markdown":"https://secwatch.observer/filing/0001193125-26-301997.md","text":"https://secwatch.observer/filing/0001193125-26-301997.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526301997/0001193125-26-301997-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526301997/d155293d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-13T20:02:20.388056+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}